What is the current valuation of the Germany biobanking market in 2024?

The overall market valuation was $5.5 Billion in 2024. Read More

What is the projected market valuation for the Germany biobanking market by 2035?

The projected valuation for 2035 is $8.5 Billion. Read More

What is the expected CAGR for the Germany biobanking market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 4.04%. Read More

Which key players are leading the Germany biobanking market?

Key players include Thermo Fisher Scientific, Qiagen, Illumina, Merck KGaA, and others. Read More

What are the main sample types in the Germany biobanking market and their valuations?

Sample types include Blood Products ($1.1 - $1.6 Billion), Tissues ($1.2 - $1.8 Billion), and others. Read More

How does the application segment perform in the Germany biobanking market?

The application segment includes Research and Development ($2.2 - $3.3 Billion) and Clinical Trials ($1.5 - $2.2 Billion). Read More

What are the end-use segments in the Germany biobanking market?

End-use segments include Academic Research Institutions ($1.1 - $1.7 Billion) and Pharmaceutical Companies ($2.0 - $3.0 Billion). Read More

What storage types are utilized in the Germany biobanking market?

Storage types include Vapor Phase Storage ($1.1 - $1.7 Billion) and Cryopreservation Storage ($2.2 - $3.5 Billion). Read More

What trends are observed in the growth of the Germany biobanking market?

The market appears to be growing steadily, with a projected increase in valuation from $5.5 Billion in 2024 to $8.5 Billion by 2035. Read More

How do the valuations of different sample types compare in the Germany biobanking market?

Tissues and Blood Products show notable valuations, with Tissues projected to grow from $1.2 Billion to $1.8 Billion. Read More

Germany Biobanking Market

ID: MRFR/MED/52633-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

Germany Biobanking Market Research Report: Size, Share, Trend Analysis By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Applications (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End Use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations) and By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Medical Device, BY Sample Type (USD Billion)
4.1.1 Blood Products
4.1.2 Tissues
4.1.3 Cells
4.1.4 Nucleic Acids
4.1.5 Microbiome Samples
4.2 Medical Device, BY Application (USD Billion)
4.2.1 Research and Development
4.2.2 Clinical Trials
4.2.3 Personalized Medicine
4.2.4 Regenerative Medicine
4.3 Medical Device, BY End-use (USD Billion)
4.3.1 Academic Research Institutions
4.3.2 Biotechnology Companies
4.3.3 Pharmaceutical Companies
4.3.4 Government Organizations
4.4 Medical Device, BY Storage Type (USD Billion)
4.4.1 Vapor Phase Storage
4.4.2 Liquid Phase Storage
4.4.3 Cryopreservation Storage
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Medical Device
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Thermo Fisher Scientific (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Qiagen (DE)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Illumina (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Merck KGaA (DE)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 STEMCELL Technologies (CA)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 BioLife Sciences (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Tecan Group (CH)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Bain Capital (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
6.3 GERMANY MARKET ANALYSIS BY APPLICATION
6.4 GERMANY MARKET ANALYSIS BY END-USE
6.5 GERMANY MARKET ANALYSIS BY STORAGE TYPE
6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
6.7 RESEARCH PROCESS OF MRFR
6.8 DRO ANALYSIS OF MEDICAL DEVICE
6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
6.12 MEDICAL DEVICE, BY SAMPLE TYPE, 2024 (% SHARE)
6.13 MEDICAL DEVICE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
6.14 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
6.15 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.16 MEDICAL DEVICE, BY END-USE, 2024 (% SHARE)
6.17 MEDICAL DEVICE, BY END-USE, 2024 TO 2035 (USD Billion)
6.18 MEDICAL DEVICE, BY STORAGE TYPE, 2024 (% SHARE)
6.19 MEDICAL DEVICE, BY STORAGE TYPE, 2024 TO 2035 (USD Billion)
6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 Germany MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
7.2.3 BY END-USE, 2025-2035 (USD Billion)
7.2.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Germany Medical Device Market Segmentation

Medical Device By Sample Type (USD Billion, 2025-2035)

Blood Products
Tissues
Cells
Nucleic Acids
Microbiome Samples

Medical Device By Application (USD Billion, 2025-2035)

Research and Development
Clinical Trials
Personalized Medicine
Regenerative Medicine

Medical Device By End-use (USD Billion, 2025-2035)

Academic Research Institutions
Biotechnology Companies
Pharmaceutical Companies
Government Organizations

Medical Device By Storage Type (USD Billion, 2025-2035)

Vapor Phase Storage
Liquid Phase Storage
Cryopreservation Storage

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓